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Abstract: The view on the significance of the presence of glycans in glycoconjugates is 
undergoing a paradigmatic change. Initially mostly considered to be rather inert and 
passive, the concept of the sugar code identifies glycans as highly versatile platform to 
store information. Their chemical properties endow carbohydrates to form oligomers with 
unsurpassed structural variability. Owing to their capacity to engage in hydrogen (and 
coordination) bonding and C-H/π-interactions these “code words” can be “read” (in Latin, 
legere) by specific receptors. A distinct class of carbohydrate-binding proteins are the 
lectins. More than a dozen protein folds have developed carbohydrate-binding capacity in 
vertebrates. Taking galectins as an example, distinct expression patterns are traced. The 
availability of labeled endogenous lectins facilitates monitoring of tissue reactivity, extending 
the scope of lectin histochemistry beyond that which traditionally involved plant lectins. 
Presentation of glycan and its cognate lectin can be orchestrated, making a glycan-based 
effector pathway in growth control of tumor and activated T cells possible. In order to 
unravel the structural basis of lectin specificity for particular glycoconjugates mimetics of 
branched glycans and programmable models of cell surfaces are being developed by 
strategic combination of lectin research with synthetic and supramolecular chemistry. 
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1. Why Glycans Are the Most Versatile Platform for Coding 
Biochemical coding can be likened to a language. Oligo- and polymers are the biochemical 
equivalents of “words” and “sentences”. Built from the alphabets of nucleotides and amino acids, the 
information content of nucleic acids and proteins is determined by the sequence (order of “letters”). In 
both cases, the “letters” are connected in the same way (type of linkage and points of attachment; 
Figure 1a,b). DNA replication and protein production are therefore possible with a minimum of 
enzymatic steps at the required high accuracy. Inevitably, limits to the coding capacity are set this way. 
It is only the order of building blocks (and no further variable) that defines the primary structure. In 
quantitative terms, permutations of building blocks are the sole factor, which generates sequence 
complexity. A certain limit of oligomer length must thus be surpassed to store information without 
ambiguities. Is a class of biomolecule available for high-density coding? 
 
Figure 1. Illustration of the linkage points for oligomer formation in biomolecules by 
arrows. The phosphodiester bond in nucleic acid biosynthesis (a) and the peptide bond in 
protein production (b) yield linear oligomers. For each reaction, the same types of 
functional groups are involved throughout polymerization. In contrast, the glycosidic 
linkage in oligosaccharides can involve any hydroxyl group, opening the way to linear and 
also branched structures (c). Using D-glucose as an example, its active form UDP-Glc 
enables conjugation of this sugar to carbohydrate acceptors to any hydroxyl group of 
carbohydrate acceptors, as symbolized by arrows directed towards the hydroxyl groups. 
The anomeric position in chain elongation can be α or β, as symbolized by two bold arrows 
pointing away from the molecule (from [1], with permission). 




Figure 2. Illustration of phosphorylated (phosphated) and sulfated (sulfurylated) glycan 
“words”. 6-Phosphorylation of a mannose moiety (in the context of a pentamannoside) is 
the key section of a routing signal (“read” by P-type lectins) in lysosomal enzymes (a),  
4-sulfation of the GalNAcβ1,4GlcNAc (LacdiNAc) epitope forms the “postal code” for 
clearance of pituitary glycoprotein hormones from circulation by a hepatic endothelial cell 
receptor, a bifunctional lectin with C-type and β-trefoil domains (b), the HNK (human 
natural killer)-1 epitope (CD57, 3-sulfated GlcAβ1,3Galβ1,4GlcNAc) is involved in cell 
adhesion/migration in the nervous system (c) and the encircled 3-O-sulfation in the 
pentasaccharide’s center is essential for heparin’s anticoagulant activity (d). All sugars are 
in their pyranose form. Please note that the central glucosamine unit has N,O-trisulfation 
and that the 2-sulfated iduronic acid (IdoA), given in the 1C4 conformation, can also adopt 
the hinge-like 2SO skew-boat structure (about 60% or more for the 2SO form in equilibrium 
depending on the structural context) when present within glycosaminoglycan chains of the 
proteoglycan heparin. 2-Sulfation of IdoA serves two purposes: favoring the hinge-like 2SO 
conformation and precluding reconversion to glucuronic acid (from [1], with permission). 
A brief look at carbohydrate biochemistry reveals the much larger potential of the sugar alphabet 
for coding: the sugar ring presents several chemically (nearly) equivalent hydroxyl groups. Each one 
(in the pyran/furan ring or in exocyclic position) can in principle be engaged in a glycosidic linkage 
with the anomeric center of the second unit in a disaccharide (Figure 1c). Connections can thus be 
made with different linkage points, from position 1 to positions 1, 2, 3, 4, or 6. As Figure 1c also 
makes obvious, the anomeric center can be in α- or β-configuration. Variation in the involvement of 
hydroxyl groups in the glycosidic linkage, together with the parameter of anomery, as highlighted in 
this figure, increases the coding capacity far beyond simple sequence permutations [2]. Each 
monosaccharide of the sugar alphabet has its characteristic set of points enabling enzymatic 
elongation. Often, each theoretically possible site is indeed recruited in glycan synthesis, as outlined 
for the “letter” L-fucose in the next paragraph. Furthermore, introduction of substitutions by 
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phosphorylation or sulfation extends the biochemical diversity of the sugar alphabet [1]. To illustrate 
these two structural aspects, i.e., variations in the glycosidic linkage and presence of substitutions, 
examples for bioactive sugar “words” ranging from a substituted monosaccharide (i.e., 6-phosphorylated 
mannose) to a pentasaccharide with several sulfate groups are given in Figure 2. In contrast to nucleic 
acid/protein biosynthesis a large number of enzymes for chain initiation/elongation and modification is 
necessary. Obviously, the enzymatic machinery (assembly line) is capable of realizing the structural 
potential of sugars [3–5]. Whatever the requirement, whether for example additions of fucose or sialic 
acid at terminal or branch positions or specific chain elongations, e.g., by β1,3-linkages, are concerned, 
a broad array of glycosyltransferases (in the order of about 200 genes) is encoded in the genome [6–11]. 
The same applies to chain-modifying enzymes, with 35 sulfotransferases known to process 
glycoconjugates in the Golgi region [12,13].  
In further contrast to nucleic acids and peptides/proteins, glycans are branched physiologically. 
Looking at standard protein glycosylation, complex-type bi- and triantennary N-glycans and a  
mucin-type core 4 O-glycan illustrate the capacity of monosaccharides to connect to three partners 
(Figure 3). At termini of glycan antennae, presence of branching is manifested by the epitopes of the 
histo-blood group ABH or Lewis systems, with fucose in α1,2-, α1,3- or α1,4-linkage [1,8,10]. Each 
linkage is formed by a distinct fucosyltransferase, the structurally related glycans have their particular 
“meaning”. As will be explained in the third section below, antibodies against blood group 
determinants were historically the first type of sugar receptors known to distinguish very similar 
“words”. Substantiating the versatility for isomer generation, even α1,6-fucosylation is possible. Not at 
termini but within the core, at the innermost N-acetylglucosamine (GlcNAc) moiety of N-glycans 
conjugated to an asparagine of the protein, an α1,6-fucosyltransferase can add the so-called core fucose 
(Figure 3a). Knock-out mice for fucosyltransferases and work with synthetic glycan chains 
without/with the substitutions have underscored that this non-random positioning indeed has its 
physiological significance [14–16]. Further looking at the core, a second type of substitution occurs in 
mammalian complex-type N-glycans: a GlcNAc moiety can be attached to the central mannose unit 
like a wedge in β1,4-linkage, referred to as the bisecting GlcNAc (Figure 3a). In the concept of the 
sugar code these intimately controlled core substitutions should have their own importance. Both the 
bisecting GlcNAc moiety and the core fucose unit are not inert additions to the N-glycan but act on its 
conformational behavior like molecular switches. They shift the conformational equilibrium and 
hereby alter the distances between terminal sugars, a key factor for affinity to receptors [17,18]. The 
realization of the role of branching for lectin reactivity has inspired synthetic work on glycoclusters, as 
further discussed in Section 6. The given examples are meant to convey the message that glycan 
assembly has reached a remarkable level of sophistication and exploits the theoretical possibilities of 
oligosaccharides for high-density coding, and this even with species-specific traits [19]. In conclusion, 
“carbohydrates form the third alphabet of life. Compared to amino acids and nucleotides their 
versatility for isomer formation (code words) is unsurpassed” [1]. 




Figure 3. Schematic illustration of physiologically branched glycans. Complex-type  
N-glycans are constituted by the invariable core pentasaccharide (Man3GlcNAc2) and the 
peripheral region, here with extension of the two antennae (a) or introduction of a third 
branch to form a triantennary N-glycan (b). The sites for introduction of core substitutions 
at the innermost GlcNAc moiety (by α1,6-fucosylation) or the central Man residue (by 
β1,4-conjugation of the bisecting GlcNAc) are labeled by arrows (a). Core branching in 
mucin-type O-glycans is based on β1,3-/β1,6-extensions from the central GalNAc moiety 
(c). For structures and preparation of synthetic mimetics of the bi- to trivalent N/O-glycans, 
please see below (Scheme 1, Figures 12–14 and Scheme 2).  
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This brief survey on glycan structures documents that simple sequence permutations are just one 
aspect of the primary structure. What is stated quite matter-of-factly has enormous consequences for 
experimental analysis. As explained above, the complete definition of any di- or oligosaccharide in 
structural terms requires the determination of the linkage points and the type of anomery. Addressing 
these issues makes carbohydrate sequencing (and synthesis) much more demanding than respective 
work on nucleic acids and proteins, explaining the origin of the often used term “complex 
carbohydrate”. As platform to store information, however, glycans offer the largest potential. Whether 
the words of the sugar language can then actually be read depends on the suitability of glycans to 
engage in interactions. This property must be assessed next. 
2. Why Glycans are Suited for Biorecognition 
Examining the structural details of glycans as presented in Figures 2 and 3 has pinpointed a fair 
abundance of hydroxyl groups. They can readily be involved in hydrogen bonding or in coordination 
bonds with an appropriately positioned cation such as Ca2+. These interactions with a receptor site do 
not only provide enthalpic gains but also topological specificity by sensing complementarity. In 
addition, the set of remaining C-H bonds, slightly polarized, has a special ability. It shapes patches or 
contiguous regions for van der Waals interactions, especially with π-electron systems, then leading to 
C-H/π-interactions, with favorable thermodynamic consequences enthalpically and also entropically 
by reducing solvent accessibility [20,21]. Moreover, substitutions by negatively charged groups such 
as phosphate or sulfate, as shown in Figure 2, add contact points for ionic binding. Overall, these 
structural features set a strong basis for free energy generation upon binding.  
When the glycan forms a complex with a partner, another factor must be considered: the binding 
process engenders changes in the spatial flexibility, e.g., by arresting a flexible molecule in a  
bound-state conformation. Automatically, this unfavorable entropy loss will need to be compensated. 
If intramolecular dynamics and structural fluctuations were limited, the extent of entropic penalty 
would be reduced, a reason to embed flexible peptide sequences into the context of proteins, that is to 
let them acquire a stable bioactive conformation. In the case of glycans, limiting the number of 
accessible conformers comes by their structural nature. The bulkiness of the pyranose rings imposes 
spatial constraints to free rotations around the glycosidic linkage. The conformational space becomes 
graded in terms of the energy, with “valleys” and “hills”, resulting in “topological” maps. As 
consequence, carbohydrates often access only a small set of energetically privileged conformers 
(“valleys” in the energy landscape) so that the sections of the energy “hills” are not populated [22–24]. 
Put metaphorically and with perspective, “the carbohydrate moves in solution through a bunch of shapes 
each of which may be selected by a receptor” [25]. Keeping in mind that synthesis of complex glycans 
depends on the binding and processing of carbohydrates by enzymes and that recognition of isomers 
by antibodies is a further physiological case of glycan binding, proteins are thus already known to be 
effective sugar receptors. Because a biomedical importance of glycans is assumed and their profile 
(glycome) is not only widely different on various cells, a challenge for analysis [26,27], but tightly 
controlled and regulated by synthesis and dynamic remodeling, especially by removing sialic acid 
from distinct chains with sialidases [28–30], one would intuitively expect an equally elaborated set of 
sugar receptors. All these factors, i.e., suitability for hydrogen/coordination bonding and  
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C-H/π-interactions, residence in energetically privileged structures, an elaborate synthetic machinery 
and ability of proteins to act as receptors, argue in favor of productive protein-glycan interactions. 
Having up to this point focused on glycans, the question is whether a panel of sugar receptors 
matching the glycomic diversity has developed, beyond the glycan-processing enzymes and  
glycan-binding antibodies. This is indeed the case, on the level of protein folds and sugar  
specificities [31]; so the tools for reading sugar-encoded information (to read, legere in Latin) are 
available. They are called lectins. 
3. Lectins: Definition and Overview 
The term has its roots in work with plant proteins that have specificity for histo-blood group 
determinants. Classically, this property is measured by detecting agglutination of erythrocytes of 
donors with different ABH(0) status [32–34]. Origin and activity of the proteins are expressed in the 
term “phytohaemagglutinin”. This assay, the haemagglutination, had been instrumental to define blood 
groups, initially by using antiserum and the capacity of auto-antibodies to cross-link erythrocytes [35,36]. 
Actually, this reaction underlies fatalities in transfusion medicine. Thus, as noted above, antibodies in 
serum were known to distinguish between such clinically relevant surface epitopes, although their 
biochemical nature had at that time not yet been disclosed. This situation prompted W. C. Boyd to 
introduce a new term for blood-group-specific proteins from plants, which are not antibodies [37]. The 
name “lectin” is thus a means “to call attention to their specificity without begging the question as to 
their nature” [37], and, fittingly, a lectin (from eel serum) was crucial to reveal fucose as key 
determinant of the H(0) epitope [38,39]. Today, this term is used for (glyco)proteins with specificity 
for carbohydrate, different from sugar-specific antibodies and enzymes as well as from 
sensor/transport proteins for free mono- and oligosaccharides [40]. Non-catalytic domains associated 
with the enzymatic center of glycoside hydrolases, mostly in bacteria and fungi, are also kept separate, 
these protein parts referred to as carbohydrate-binding modules [41]. Because assays for lectin detection 
(for survey please see [42]) and powerful affinity chromatography (introduced 1965 [43]) paved the way 
for purification, it became possible to answer the question whether lectins are rare or frequent 
inventions during phylogenesis. 
Crystallographic analysis of lectins is able to assign any protein to one of the many families based 
on the domain (fold) structure. Systematic classification has discovered more than a dozen folds in 
vertebrates with ability to accommodate a glycan [31,42]. A certain module can even be a scaffold for 
different groups of lectin, with the contact site for the ligand located in various regions of the common 
fold, as is the case for the β-sandwich [31,42,44]. Initially found in leguminous lectins (here 
concanavalin A [45]), this fold is characteristic for the pentraxins, galectins (please see Figure 4a and 
Section 4) and mannose-specific lectins in glycoprotein quality control and routing from the 
endoplasmatic reticulum to the Golgi [31,42,44]. Obviously, sugar recognition by lectins, in terms of 
number of folds and of fold usage, is not a singular event in Nature. Both glycan and lectin structures 
can reach equal levels of sophistication. Illustration of three examples of carbohydrate recognition 
domains (CRD) of mammalian lectins exemplifies the diversity of folds (Figure 4). Notably, the  
C-type fold (Figure 4b) harbors a Ca2+ in its center for topologically specific interplay with the ligand, 
a case of direct contact between the strategically positioned cation and the glycan, embedded in a 
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network of hydrogen bonds between sugar and protein [41,46]. This orchestrated constellation, a 
sensor for complementarity, ensures monosaccharide specificity. Combined with the presentation of  
C-type lectin domains in a trimer, it explains the high avidity of binding of the hepatic lectin to the 
topologically complementary branch ends of the complex-type triantenary N-glycan, shown in  
Figure 3b [47–49]. Lectin sites thus cooperate and “read” both sugar structure and mode of presentation. 
The sequencing of lectin genes disclosed a functionally salient structural aspect beyond the contact 
site to the glycan: the lectin domain can be associated with other types of modules to establish a 
mosaic of active sites [50,51]. Membrane-spanning sections, regions for forming α-coiled coils or 
(non-)triple helical collagen-like repeats for oligomerization, immunoglobulin-like (or sushi) repeats as 
spacers or as sites for recognition of other types of ligand, even other types of CRDs (a β-trefoil 
domain in the tandem-repeat-type (C-type) mannose receptor active in “reading” the “postal code” for 
delivery (clearance) of pituitary glycoprotein hormones (please see Figure 2b for epitope structure) or in 
lecticans binding hyaluronic acid), to list several examples, are encountered in this respect [52–56]. 
The structural organization in oligomers mentioned above is thus facilitated, as required for target 
specificity in the case of the just mentioned asialoglycoprotein receptor or of serum collectins [1,57–59]. 
In fact, there is a wide spectrum of functional cooperation between modules: different sites in a protein 
can interact with binding partners toward a certain end. In the case of lectin (discoidin I)-mediated 
ordered cell migration, sugar binding is recruited for lectin secretion from the slime mold cells, the 
lectin’s RGD site of extracellular lectin then for transient cell contacts with a cell surface receptor [60]. 
The large number of folds and the wide variety of structural contexts, in which CRDs occur, are strong 
arguments in favor of a broad physiological significance of lectins. 
 
Figure 4. Illustration of three common lectin folds in complex with a ligand.  
(a) The β-sandwich of human galectin-1 in complex with the disaccharide lactose (PDB 
code 1GZW); (b) the C-type CRD of human E-selectin with its Ca2+ (yellow sphere) in 
complex with the tetrasaccharide sialyl Lewisx (CD15s) (PDB code 1G1T); (c) the  
I(gG)-type CRD of the murine siglec sialoadhesin (siglec-1) in complex with the 
trisaccharide 3'-sialyllactose (PDB code 1QFO). 
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Having started their success story in hematology, lectins soon acquired the status of versatile 
reagents for glycan localization, isolation and characterization. Together with carbohydrate-specific 
(monoclonal) antibodies they have enabled a wealth of studies, collecting ample evidence for glycan 
presence and dynamics of regulation, spatially and structurally in cells and tissues. Carbohydrate 
specificity of a lectin was first detected in the case of concanavalin A by precipitation assays in 1936: 
“one part of glycogen in 500,000 parts of water will give a perceptible haziness if allowed to stand 
after the addition of excess of concanavalin A. In as much as this precipitation resembles the reaction 
between antigen and antibody, where the glycogen takes the part of the hapten, we were interested in 
investigating it.” [61]. The authors concluded that the hapten-like molecule, with which concanavalin 
A “unites, may be a carbohydrate group” [61]. Nowadays, a wide panel of methods will evaluate 
carbohydrate binding (for review, please see [42]), technically simply measured by high-throughput 
arrays [62,63]. These data sets are helpful to interpret results from the application of labeled lectins in 
routine cyto- and histochemistry, especially when regional or temporal regulation has been  
observed [64–67]. The bisecting GlcNAc residue, to epitomize the intimate connection, is readily 
localized by the bean lectin PHA-E (E: erythroagglutinin) [68]. That said, each lectin entering the list 
of reagents could open the door to new insights on specific epitopes so far not mapped. The broad 
screening for lectin activities in diverse plants, fungi and mushrooms thus has notable merit beyond its 
descriptive outcome, that it is to identify new tools with particularly useful features. The agglutinin 
from the mushroom Polyporus squamosus sets an excellent example in this respect. 
This lectin is specific for the α2,6-sialyl branch end of N-glycans [69–71]. Sialylation can entirely 
change the bioprofile of a glycan branch, by reducing intermolecular interactions through charge 
repulsion passively or by switching off/on ligand avidity for lectins (such as galectins or siglecs) 
actively. Based on studies in cell biological models, in which expression of distinct genes such as 
tumor suppressors or oncogenes can be activated/silenced and the impact of the manipulation on 
glycosylation be defined, especially lectins with specificity to α2,3/6-sialylated epitopes (or to  
N-glycan core substitutions) have diagnostic value [72–74]. The detection of such changes then 
prompts to trace their physiological relevance. Toward this aim, the possibility of a productive 
interplay with an endogenous lectin constitutes an attractive hypothesis for further work. Whereas 
lectins from other (exogenous) sources substantiate presence of an epitope, lectin presence in situ 
could be the missing link between a glycan and a process. With hindsight somewhat surprisingly, it 
took more than two decades to bridge the gap from the rather popular phytohaemagglutinins (the 
synonym for plant lectins) to lectins in mammals, the large lectin contents in seeds (for concanavalin  
A about 2.1 g/100 g) probably being a factor. Pioneering studies on the role of sialic acid 
(presence/absence) in serum clearance of the glycoprotein ceruloplasmin led to the purification of the 
first mammalian lectin (from rabbit liver) [75–77]. Explicitly, this work proved that a glycan “word” 
can be “read” by an endogenous lectin, like a postal code by a delivery service, putting endogenous 
sugar receptors on the research agenda. Considering the diversity of glycan structure and the dynamics 
of changes, postulating broad functional facets of lectin-glycan recognition in situ is indeed an 
appealing concept that commands attention. Perspectives for applications first led to establish a solid 
foundation by searching for sugar receptors, then studying in detail each detected lectin from its gene 
and protein structures to the expression profile, finally the interaction with counterreceptors and its 
physiological consequences. 
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Ideally, all members of a lectin family are analyzed together comprehensively in direct comparison. 
In principle, even two related proteins can have diverged to a level that their activity profiles will not 
or only to a small extent overlap. As domains in a multimodular protein do, individual family members 
may also cooperate in a network. What sounds rather academic and complex can best be illustrated by 
looking at the research strategy and emerging results in the case of a distinct family, preferably with 
biomedical relevance. In view of their involvement in diverse processes such as cell adhesion, growth 
regulation, mediator release and migration as well as intracellular activities such as regulation of gene 
expression or apoptosis [31,41,51,52,78–82], galectins serve as such an instructive test study object. 
They are lectins with specificity to a β-galactoside core, a β-sandwich fold (shown in Figure 4a) and a 
conserved sequence signature with a central Trp moiety for ligand contact via C-H/π-interactions [83]. 
The set of conserved amino acids is shown in Figure 5, as illustration of the carbohydrate-binding site 
and as sequence for three closely related homodimeric avian lectins. When inspecting Figure 5, the 
crucial Trp residue is easily spotted in the carbohydrate-binding sites of the three galectins. 
 
Figure 5. Comparison of the carbohydrate-binding sites (A) of the proto-type chicken 
galectins CG-1A (a, PDB code 1QMJ), CG-1B (b, PDB code 3DUI) and CG-2 (c, PDB 
code 2JMZ). The sequences (B) provide information on deviations in the vicinity of the 
conserved residues (in red), which contact the ligand.  
The first member of this family was isolated from the electric organ of Electrophorus electricus in 
1975 [84]. In this case, the classical haemagglutination assay and the inhibition of activity by lactose 
gave direction to purification, which was greatly favored by the presence of a reductive agent  
(β-mercaptoethanol) to protect this lectin from oxidation [83]. Ensuing work, first on the level of 
proteins, later of genes, has thoroughly mapped galectin presence in vertebrates and defined the 
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intrafamily diversity, especially due to the growing number of sequenced genomes. Database mining, 
an approach to search for genes satisfying the criteria for homology and also for gene duplications, as 
successfully done for mammalian galectin-7 (Gal-7) [85], has substituted work in the cold room and 
peptide fingerprinting to draw a genealogical tree for the protein family. Doing so for galectins led to 
three branches. 
4. Galectins: A Model to Trace Lectin Divergence 
Assignment of a galectin to each of the three categories is done by the structural mode of presenting 
the CRD. Two nomenclature systems are in use. They separate the proto-type (homodimeric), the 
tandem-repeat-type (two different CRDs covalently connected by a linker) and the chimera-type form, 
in which the CRD is associated with a tail (non-triple helical collagen repeats and a peptide with two 
sites for serine phosphorylation) [31,51,52,86]. Remarkably, occurrence of diversification is confined 
to the first two groups, whereas galectin-3 (Gal-3) is the sole chimera-type protein. On the level of the 
genes, galectins from the three groups in diverse organisms share a common exon-intron architecture. 
This conservation is illustrated exemplarily in Figure 6. These obvious traits of phylogenetic 
relationship, documented for avian and mammalian genes in Figure 6, have important implications for 
the selection of the model organism for studies aimed at delineating consequences of the intrafamily 
divergence. In other words, for a comprehensive study, a species with minimal number of galectin 
genes covering all three groups should best be suited for detailed characterization of structural aspects, 
binding properties and expression. With a total of five canonical proteins, the chicken galectins (CGs) 
fulfill this criterion [52,87,88]. Reflecting the high degree of homology to mammalian orthologues, 
they are referred to as CG-1A/B and CG-2 (proto-type), CG-3 (chimera-type) and CG-8  
(tandem-repeat-type). 
Moving from gene to protein sequence and then to folding [89–91], a common theme emerging 
from the comparison of crystal structures of the three proto-type CGs is the occurrence of sequence 
deviations in the vicinity of the strictly conserved residues (Figure 5). The architecture of the 
carbohydrate-binding sites given in panel (A) and the amino acid sequences to peruse substitutions (B) 
document both the homology and the divergence (Figure 5). As test case, the paralogues  
CG-1A/B, arisen from a gene duplication after separation of lineages of birds and mammals [92], are 
readily distinguishable (Figure 5). The changes in their sequences intimate consequences for the 
interaction with ligands. Assays with free glycans and glycoproteins revealed differences in binding to 
histo-blood group AB determinants and the type I N-acetyllactosamine (Galβ1,3GlcNAc) core 
between CG-1A/B [93,94]. Of note, exclusively CG-1B reacts to lactose binding in solution with a 
structural compaction measured as increase (by 5.6%) of the diffusion constant [95]. In addition to 
structural aspects of the protein, mapping regulatory gene sequences comparatively is equally 
important. Set in relation to the coding sequences of these galectin genes, the extent of deviations is 
relatively higher in the promoter regions [96–98]. The fact that presence of sequence motifs for 
binding transcription factors is subject to marked changes points to individually distinct  
expression profiles. 




Figure 6. Phylogenetic conservation of galectin genes in vertebrates. For comparison, the 
structural organization of a gene from each group (Galectin-1: a proto-type protein with 
one CRD; Galectin-3: a chimera-type protein with one CRD attached to an N-terminal tail 
with a peptide and non-triple helical collagen-like repeats; Gal-8: a tandem-repeat-type 
protein with two different CRDs covalently connected by a linker peptide, present in two 
lengths due to alternative splicing) is presented, and this for man, mouse and chicken. 
Exons are given as boxes (colored when coding, further marked with a star when coding for 
the carbohydrate-binding sites), introns and 5'/3'-untranslated sequences as lines (lengths 
drawn in proportion). Arabic numbers provide sequence lengths, Roman numbers order of 
exons. The dashed line in exon III of the Galectin-3 gene depicts the repeat section, the green 
coloring of Roman exon numbers in the gene for Galectin-8 the coding for the linker 
peptide (34/76 amino acids in man, 33/42 amino acids in mouse, nine/28 in chicken). 
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This is indeed the case. Using galectin-type specific antibodies, protein presence and localization 
can be determined in tissue sections (for detailed description of the quality controls for the antibody 
preparations and technical details of the immunohistochemical processing, please see [96–98]). Thus, 
the resulting microphotographs will answer the question on similarities and differences, especially if 
consecutive sections are stained and data presented for comparison. As graphic example, the series of 
Figures 7–9 presents immunohistochemical detection of the five CGs in chicken kidney and ureter 
(together with the negative control to exclude any antibody-independent staining).  
In the different parts of the avian urinary system, that is cortex (Figure 7), the medullary region 
(Figure 8) and finally ureter (Figure 9), qualitative differences and cell-type-specific positivity are 
seen. To exclude a false-negative result it is instructive to note that, by monitoring profiles in other 
regions and organs with these antibody preparations, CG-1B is detectable in respiratory epithelium or 
stratum intermedium of the epidermis, CG-2 in epithelial lining of the gut, along with CG-3 [88,96,98]. 
Measuring responsiveness to inducers of differentiation, also under the control of promoter sequence 
elements (for murine Gal-1 induction by butyrate, it is the 5' proximal Sp1 site at −57 [99]), extended 
the evidence for individual expression patterns, both for CG-1A/B and for human galectins, indicating 
similar cross-species reactivity [100,101]. Because a conserved gene architecture for murine genes was 
depicted in Figure 6, it is fitting to add that an immunohistochemical study on six galectins (−1, −2, 
−3, −4/6 and −7) in the digestive tract of mouse confirmed the conclusion on a network, on the levels 
of mRNA and of protein [102,103].  
In summary, the sequence divergence (in coding and promoter sections) establishes a team of 
proteins with overlapping specificities for β-galactosides and individual expression profiles. In contrast 
to an expectation for rather similar (redundant) expression profiles of these homologous proteins, up to 
qualitative differences are observed in immunohistochemical monitoring of the five CGs, a result 
obtained for several vertebrate species. With medical relevance, studies on human tumors with more 
than one antibody further validate this network concept (for recent review, please see [104]). Galectins, 
in the avian model and in mammals, appear to be suited for distinct functions in a tissue- or  
cell-specific context, and this message can be extrapolated to other classes of lectins like C-type lectins 
and siglecs (for illustration of these folds, please see Figure 4b,c; for introductions to structural 
divergence in these lectin classes, please see [53,55]). However, that does not necessarily mean that there 
are no alterations between lineages and species. For galectins, the presence of genes can be species- or 
even strain-specific, in the cases of rat galectin-5 and mouse galectin-6, respectively [105–108]. The 
size of the CD33 group of siglec genes is markedly different between rodents and man, the 
consequence of a loss in respective coding sequences [109,110]. By the way, siglec binding to glycans 
requires presence of a sialic acid. Its detection in a distinct linkage type, for example in α2,6-linkage, is 
therefore possible not only by fungal, plant or slug lectins, as mentioned above for the Polyporus 
lectin, but also by human siglecs such as CD22 [111]. Connecting to the application of plant lectins for 
glycan detection, localization (glycophenotyping) and characterization, it is obvious that this approach 
using endogenous receptors will go beyond the descriptive level. 




Figure 7. Schematic illustration of the chicken urinary system and its distinct regions on 
three levels of microscopical magnification. Starting with the lobus (dashed square, top, 
with the cortex region highlighted by the grey arrow), uriniferous tubules of the lobules 
(dashed square, middle) in the kidney cortex are organized in consecutive segments, given 
in different colors (bottom). Arrows in respective color point to these regions in the 
microphotographs of immunohistochemical galectin localization (bar = 25 µm). Control 
section was processed to reveal any antigen-independent staining (no incubation step with 
antibody in otherwise identical processing). Comparison of staining profiles discloses a 
qualitative difference in expression of the proteins of the paralogue pair CG-1A/B. On the 
cellular level, CG-2 and CG-3 were seen in cytoplasm and nuclei, CG-1A and CG-8 were 
confined to the cytoplasm. 




Figure 8. Schematic illustration of the chicken urinary system with focus on the medullary 
part of the kidney (top, grey arrow) with its collecting ducts and thick loops. Arrows in 
respective color point to these regions in the microphotographs (bar = 25 µm). Segmental 
specificity was revealed for CG-1A in epithelial lining of thick loops and CG-2 in 
collecting ducts, whereas no CG-1B could be detected and CG-8 positivity was exclusively 
seen in the connective tissue. 




Figure 9. Schematic illustration of the chicken urinary system with focus on the ureter and 
its branches (top, grey arrow). Urine from secondary branches reaches the ureter 
constituted histomorphologically by the three parts given (left, bottom). CG-3 positivity 
was confined to the infranuclear portion of epithelial cells, CG-1B/CG-8 to connective 
tissue, while CG-1A was detected in all three layers (bar = 25 µm). 
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5. Endogenous Lectins as Tools and Effectors 
As done with plant lectins, a tissue receptor can be labeled under activity-preserving conditions to 
become a laboratory tool. Lectin histochemistry with endogenous receptors determines tissue reactivity 
for each type of tested protein, and the question is whether similar proteins will differ in binding to 
tissue sections. As exemplarily illustrated in Figure 10, staining patterns can be non-uniform in a 
section, confined to a region, and indeed different in comparison between galectins. Combined with 
immunohistochemistry, localization of lectin and of sites accessible to a lectin can be visualized in the 
same section (Figure 10G–I). These binding features can then be correlated to biological processes or 
to the clinical course of a disease such as tissue fibrosis or malignancy. Assessing binding capacity 
with a galectin in human tumors, Gal-3 has been documented to be of prognostic relevance in two 
types of carcinoma [112,113]. To biochemically identify and characterize endogenous 
counterreceptors, affinity chromatography and co-immunoprecipitation of lectin-glycoconjugate 
complexes coupled with mass spectrometric identification of the binding partners have proven 
instrumental. Respective work identified laminin and carcinoembryonic antigen as counterreceptors in 
human colon cancer cells [114] (please see also below for counterreceptors active in negative growth 
regulation). Of note, work on mammalian lectins in general disclosed that they bind to rather few 
cellular glycoconjugates, therefore termed counterreceptors. The reasons for restrictions on epitope 
presence on glycoproteins and for homing in on only few targets are not yet fully understood, an 
incentive for research. Of practical value, tissue lectins can be used as tools in an as versatile manner 
as plant lectins are, with the perspective for delineating physiological significance. 
 
Figure 10. Cont. 




Figure 10. Galectin histochemical detection of accessible binding sites for tissue lectins  
in the kidney cortex (A,B), medulla (C), secondary branches of the ureter (D,E) and the 
ureter (F). The color coding of the arrows follows the segmental coloring for cortex and 
medulla (top, right). An examplary control for inhibition by the cognate sugar is shown as 
inset in panel B. Very distinct staining is detected on apical surfaces in the epithelial lining 
of renal tubule segments in the cortex for CG-1A and for CG-3 in the apical region of 
secondary branches of the ureter (E). Co-localization of galectin and accessible binding 
sites by fluorescence microscopy in cortex (G) and ureter (H) revealed availability of 
reactive sites. Sequential application of two fluorescent CGs disclosed regional specificity 
of binding sites for CG-1A in the ureter (I). Mostly lumen and small areas of the 
epithelium (CG-1A) and apical surface of the epithelium (CG-3) were positive. For 
technical details of galectin labeling and of the galectin histochemical staining protocol, 
please see [111–113]. Bar = 25 µm. 
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Turning to a CG in functional terms, a role in avian limb skeletal morphogenesis has been inferred 
both by its detection at prospective sites of condensations in the embryo and by formation of regular 
arrangements of the mesenchymal cells by the homodimeric CG-1A [115]. The underlying principle of 
the cross-linking of cells by the lectin is illustrated schematically in Figure 11. Working as effector, 
lectin-dependent aggregation of glycoconjugates (lattice formation) on the surface is then followed by 
outside-in signaling, leading to differentiation [115]. Shifting the balance between proliferation and 
anoikis/apoptosis, inducing mediator release, stimulating cell migration and invasive properties and 
protecting the host by defense reactions based on recognizing microbial surface epitopes belong to the 
activity spectrum of galectins (for review, please see [41]). Selected examples presented in the next 
paragraph illustrate the intimate interplay with regulatory events on glycan synthesis for effector activity. 
 
Figure 11. Illustration of the assumed role of homodimeric CG-1A to bridge precartilage 
mesenchymal cells. This CG targets specific glycoconjugates, which can be considered as 
functional biomarkers for prospective sites, where condensations will be formed [115]. In 
addition to cell aggregation (trans-interaction) crosslinking of cell surface glycoconjugates 
(cis) can trigger outside-in signaling to promote differentiation and proliferation. Of note, 
human cartilage expresses several galectins, with correlation to the state of degeneration in 
osteoarthritis [116].  
Activity of a lectin strictly depends on the presence of the cognate counterreceptor(s). As noted 
above, despite the abundance of glycans on the cell surface, tissue lectins have the ability to sense 
structural and topological factors for this productive interplay. They are grouped into six categories: 
the specificity to mono- or disaccharides (level 1) and to oligosaccharides (level 2), the selection of 
oligosaccharide shape (conformer) from an equilibrium (level 3), the preference to particular spatial 
presentations of glycan chains in a glycoprotein with respect to orientation of branches and to clusters 
of headgroups in bi- to pentaantennary glycans (level 4) and to clusters of headgroups of neighboring 
chains in a glycoconjugate (level 5), finally the preference to glycan presentation in microdomains or 
similar aggregates (level 6) [41]. In the case of galectin-1 (Gal-1) and induction of apoptosis, the glycan 
counterreceptor is the mucin-type core 2 O-glycan structure on prostate (LNCaP) cells [117], on 
activated effector T cells it is the pentasaccharide of ganglioside GM1 [118]. In both cases, clustering of 
cognate headgroups (covalently by branching as seen in Figure 3c or non-covalently in microdomains) 
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is most likely a discriminatory feature. In fact, harming microdomain integrity by extracting cholesterol 
from neuroblastoma cell membranes caused an about 10fold decrease in affinity for Gal-1 [119]. 
Remarkably, the lectin, depending on the cellular context, “reads” different glycans, presented by a 
glycoprotein as N- or O-glycosylation and a glycolipid such as GM1. On the glycoprotein level, CD7, 
CD43, CD45 or an integrin are the functional counterreceptors to start Gal-1-triggered signaling 
toward T cell apoptosis/carcinoma growth arrest [120–126]. Of note, the homodimeric Gals-2 and -7 
use separate effector pathways in the caspase cascade toward the same end, that is programmed cell 
death of activated T cells [127]. In situ, both lectin and glycan expression can be intimately co-regulated 
toward an optimal effect. Here, master regulators appear active, as delineated for anoikis induction in 
pancreatic cancer cells (Capan-1) in vitro by tumor suppressor p16INK4a via upregulation of Gal-1  
(the lectin) and the fibronectin receptor (also termed α5β1-integrin, the protein scaffold) as well as the 
downregulation of sialic acid biosynthesis to increase responsiveness to Gal-1 by reducing  
α2,6-sialylation, a block to Gal-1 binding [73,128]. At the same time, Gal-3 is downregulated, because 
it would competitively block Gal-1 binding without inducing pro-anoikis signaling via the  
α5β1-integrin [129]. The difference in CRD presentation (homodimer vs. monomeric CRD with tail) 
underlies this functional disparity, a case of functional antagonism between galectins. Obviously, the 
way of cross-linking within the resulting complexes on the cell surface is crucial for triggering the 
response. Thus, in addition to the glycan sequence, local density by clustering in a glycoprotein (level 4), 
as shown in Figure 3, can be a factor to predestine sites for lectin binding. This assumption must be 
verified experimentally, a difficult task on the level of cells, where engineering with surgical precision 
is hardly possible. To start with simple systems and then to increase the complexity stepwisely in 
model studies for delineating respective structure-activity relationships is possible for synthetic and 
supramolecular chemistry. The first step into this direction is to prepare a synthetic core presenting 
several glycans (glycocluster). 
6. From Glycoclusters to Artificial Cell Surfaces 
The intention for the design of scaffolds with several attachment points for carbohydrates is to 
mimic the branched display of N- and O-glycans. Having identified spatial vicinity as a regulator of 
lectin affinity, e.g., on level 4, the synthetic work can provide tools for delineating structure-activity 
profiles. In this sense, placement of sugar headgroups may even access non-physiological constellations, 
in efforts to optimize affinity and/or selectivity. To qualify as core, the prerequisites of solubility and 
lack of toxicity must be satisfied, and conjugation of sugars should be possible in a straightforward 
manner, as is often the case [31,130]. To offer a graphic example, Scheme 1 documents the steps to a 
trivalent glycocluster starting from 1,3,5-trihydroxybenzene (1) using copper-promoted azide-alkyne 
cycloaddition, and a tetravalent scaffold was produced by the same pathway (for details, please  
see [131]). Their spatial features of ligand presentation were then characterized by molecular 
modeling. Resulting low-energy conformers with the average distances between the sugars in the 
different branches are shown in Figures 12–14. These intramolecular parameters in the artificial 
glycoconjugates lie in the range of what is for example characteristic for a complex-type triantennary 
N-glycan, as shown above in Figure 3b, a high-affinity ligand for the hepatic asialoglycoprotein 
receptor [49]. With respect to galectins, their association to each branch end of the bi- and triantennary 
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N-glycans of the glycoprotein asialofetuin has been ascertained by precipitation and calorimetry [132,133]. 
To test whether this design enhances the bioactivity of the artificial glycoconjugates, assays 
monitoring lectin binding to a glycoprotein and to cells were performed in the absence and presence of 
the synthetic compound, measuring extent of signal reduction [31]. The synthetic glycoclusters could 
block the lectin to a certain extent. The tetravalent compound was more potent as inhibitor for Gal-3 
than for proto-type galectins, a result that underlines the impact of topological presentation [131]. A 
further increase in activity and selectivity of this glycocluster was achieved by headgroup tailoring, 
extending the disaccharide lactose to the H(0) trisaccharide (Scheme 2) [131].  
Inversely, tailoring protein features-while keeping the glycocluster design constant-will raise 
evidence for functional structure-activity implications from the side of the protein. A pertinent 
question, to illustrate practical aspects, is what presence and length of the linker in tandem-repeat-type 
galectins mean for the protein. Engineering on the cDNA level is a way of generating new  
non-physiological variants of the natural proteins for comparative testing. Shortening the  
42-amino-acid-long linker of human galectin-4 (Gal-4) reduced the inhibitory activity of a bivalent 
1,4-diethynyl-benzene-based compound more than 20fold [134]. This result is in line with a rather 
flexible linker, which allows the two CRDs to adapt to slightly different topologies of glycan 
presentation. This way, two types of counterreceptors can be brought together, e.g., in Gal-4-mediated 
apical or axonal transport [135,136]. 
Thus, spatial characteristics on both sides (i.e., glycan and lectin) alter reactivity and lead to an 
optimal fit, in cis- and in trans-interactions. This mutually matching orientation is the basis of the 
lectin-dependent cell aggregation shown in Figure 11. Because this process, also cell adhesion to a 
matrix as well as initiation of signaling all depend on cell surface binding, tailoring a substratum 
(mono- or bilayers) or liposomes, also termed nanoparticles, accordingly affords access to respective 
platforms for the next steps of testing, that is to build models for levels 5 and 6 of affinity regulation. 
Natural or synthetic glycolipids, together with cholesterol and glycerophosphatides, can be chosen to 
mimic membrane properties, even at array format [137], and this increasingly so in an iterative series. 
Self-assembling amphiphilic Janus dendrimers are another starting set for programmable vesicles of a 
size of choice [138,139]. While studies on a monolayer surface will provide insights into binding and 
reorganization of monolayer constituents (cis-interactions), monitoring aggregation of liposomes or 
glycodendrimersomes characterizes trans-interactions. Admittedly, refining the models to come into 
the vicinity of the natural complexity of cell membranes will take quite a series of steps. Toward this 
end, teaming up synthetic and supramolecular chemistry with protein biochemistry will be 
instrumental. This strategy will help us understand the intriguing counterreceptor specificity by 
simulating natural systems and purposefully testing parameter changes. 




Scheme 1. Synthetic routes to the trivalent (1) and tetravalent (2) glycoclusters via copper-
promoted azide-alkyne cycloaddition as central step using 1,3,5-tris(alkynyloxy)benzene 
(4) and 2-(3,5-bis(3,5-bis(prop-2-ynyloxy)benzyloxy)benzyl)isoindoline-1,3-dione (5) (for 
experimental details, please see [131]).  




Figure 12. Computer-based estimation of the distances between branch ends of the  
1,3,5-trimethoxybenzene-based trivalent glycocluster 1 (for synthetic route, please see 
Scheme 1) and presentation of the conformer with C-3 symmetry. Dynamic fluctuations in 
space and time enable the glycocluster to access conformers with distances between  
20–25 Å, then losing the C-3 symmetry. 




Figure 13. Computer-based estimation of the distance profile between branch ends of the 
tetravalent glycocluster 2 based on a 1,3-bis(3,5-dimethoxybenzyloxy)benzene core (for 
synthetic route, please see Scheme 1). The rectangular arrangement accounts for 
approximate distances of 19, 26 and 32 Å. For a conformer with tetrahedral arrangement of 
branch ends, please see Figure 14. 




Figure 14. Distance profile of a conformer of the tetravalent glycocluster 2 with tetrahedral 
branch arrangement. As noted above for the trivalent compound, dynamic fluctuations in 
space and time will alter the distance profile to a limited extent. 




Scheme 2. Synthetic route to the trivalent glycocluster with the histo-blood group  
H(0)-like trisaccharide headgroups (12). Following introduction of the fucosyl moiety 
using donor 8 into the appropriately protected acceptor 7 and the conversion to the azide 
11, the copper-promoted coupling with the alkyne 4 produced the trivalent glycocluster 12 
with its trisaccharide (for experimental details, please see [131]).  




The intricacies of cell sociology depend on the presentation of a multitude of signals with distinct 
information content on the cell surface. Because the available space is limited, the structural platform 
must make high-density coding possible. In chemical terms, more than the sequence is then required 
when synthesizing oligomers. Carbohydrates fulfill this prerequisite to its full extent, and the 
ubiquitous presence of glycans (as part of glycoconjugates or as saccharides of variable chain length) 
led N. Sharon to boldly state that “we know that the specificity of many natural polymers is written in 
terms of sugar residues, not of amino acids or nucleotides”, although the excitement raised by the 
insights into glycan diversity “should not hide the fact” that we are just beginning to understand the 
rules of the sugar code [140]. Determinants of this third alphabet of life offer contact points for 
interactions, and they can be used by endogenous receptors (lectins). Their presence spread over more 
than 12 families in mammals stimulates research activities to map characteristics of each lectin 
thoroughly. The phylogenetic divergence within the lectin families and the development of individually 
regulated expression patterns, with the possibility for co-regulation in counterreceptor presentation, are 
strong arguments for the assumedly productive lectin-glycan recognition. To answer the question on 
how its intriguing specificity is achieved, that is how the right partners are brought together to turn 
sugar coding into cellular activities, is a demanding challenge. Merging the sophistication of synthetic 
and supramolecular chemistry with biochemical and cell biological approaches to continue to dissect 
sugar coding by glycoconjugates and cell surfaces in detail is the methodological answer. This gives a 
reason to substitute the term “glycobiology” by “glycosciences”, which reflects the interdisciplinarity 
of the field. 
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